Drug Prices

18 posts

Conditional Approval and Pricing of New Drugs – Asrar Qureshi’s Blog Post #1313

Asrar Qureshi’s blog delves into the complex journey of health innovations from discovery to patient access, highlighting the significant costs and time involved in drug development. It emphasizes the need for a collaborative approach between pharmaceutical companies and governments to address pricing, making life-saving medications accessible while managing risks and uncertainties effectively.
Share
View Post
  • 6 min

Colossal Wrongdoings by Big Pharma – Insulin Price Gouging – Asrar Qureshi’s Blog Post #1092

The blog post discusses the insulin price gouging crisis that began around 2000, with prices soaring due to manipulation by major manufacturers Eli Lilly, Novo Nordisk, and Sanofi. This crisis has significant implications for patients’ health and financial well-being, highlighting ethical issues in pharmaceutical capitalism and calling for urgent reform to ensure accessibility.
Share